investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Large Databases of Small Molecules - Drug Development Tool and Public Resource

Marc Nicklaus

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Peter Ertl

Novartis (Switzerland)

Basel, Switzerland

Sorel Muresan

Lund University

Lund, Sweden

AstraZeneca (United Kingdom)

London, United Kingdom

Dmitry Katsubo

European Patent Office

The Hague, Netherlands

Related projects

Daniela Salvemini

A3AR Agonists to Prevent Chemotherapy-Induced Painful Peripheral Neuropathy

All cancers but non-melanoma skin cancer

Julian Downward

Investigation of circulating tumour DNA in the early detection of KRAS and EGFR mutant cancers

All cancers but non-melanoma skin cancer

Elliot Chaikof

A PSGL-1 Glycopeptide Mimetic for Treatment of Venous Thromboembolism

All cancers but non-melanoma skin cancer

Wenyi Wang

Statistical methods for genomic analysis of heterogeneous tumors

All cancers but non-melanoma skin cancer

Peter R Parham

Interactions Between HLA Class I and Cytolytic Lymphocytes

All cancers but non-melanoma skin cancer

Hiroaki Mitsuya

Development of Antiviral Therapy of HIV-1 Infection

All cancers but non-melanoma skin cancer

Xuemei Zhong

In vivo study of a unique phagocytic L2pB1 B lymphocyte in diet induced obesity

All cancers but non-melanoma skin cancer

Richard L Haspel

A National Curriculum in Cancer Genomics for Pathology Residents

All cancers but non-melanoma skin cancer

Pathology

Shawn B Bratton

Degradation mechanisms for inhibitor of apoptosis proteins and their antagonists

All cancers but non-melanoma skin cancer